N Ogawa Selected Research

N Ogawa Research Topics

Disease

5	Parkinson Disease (Parkinson's Disease) 01/2005 - 06/2000
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2004 - 01/2000
4	Ischemia 04/2001 - 01/2000
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2012 - 01/2000
3	Parkinsonian Disorders (Parkinsonism) 01/2005 - 06/2000
3	Alzheimer Disease (Alzheimer's Disease) 01/2004 - 01/2000
2	Deglutition Disorders (Dysphagia) 01/2022 - 01/2022
2	Lymphoma (Lymphomas) 10/2005 - 08/2001
2	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2002 - 02/2001
2	Lymphatic Metastasis 10/2001 - 02/2001
2	Adenocarcinoma of Lung 10/2001 - 02/2001
2	Neoplasms (Cancer) 07/2001 - 02/2001
1	Shock 01/2019
1	Vascular Calcification 04/2013
1	Type 2 Diabetes Mellitus (MODY) 03/2013
1	Brain Death (Brain Dead) 01/2009
1	Essential Hypertension 10/2005
1	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2004
1	Virus Diseases (Viral Diseases) 12/2003
1	Hemorrhagic Cystitis 12/2003
1	Hypersensitivity (Allergy) 10/2002
1	Idiopathic Pulmonary Fibrosis 10/2002
1	Pneumonia (Pneumonitis) 10/2002
1	Vascular Diseases (Vascular Disease) 10/2002
1	Cysts 11/2001
1	Spinal Diseases (Disease, Spinal) 08/2001
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 08/2001
1	Febrile Neutropenia 07/2001
1	Multiple Myeloma 07/2001
1	Neutropenia 07/2001
1	Hematologic Diseases (Blood Diseases) 02/2001
1	Fibrosis (Cirrhosis) 02/2001
1	Stomach Neoplasms (Stomach Cancer) 02/2001
1	Asthma (Bronchial Asthma) 02/2001
1	Aplastic Anemia (Anemia, Hypoplastic) 02/2001
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2001
1	Nephritis 01/2001
1	Glomerulonephritis 01/2001
1	Polyps 12/2000

Drug/Important Bio-Agent (IBA)

3	ImmunophilinsIBA 01/2004 - 12/2000
3	LigandsIBA 01/2004 - 12/2000
3	Metallothionein 3IBA 02/2001 - 01/2000
2	Proteins (Proteins, Gene)FDA Link 01/2005 - 02/2001
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2004 - 02/2001
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2004 - 08/2001
2	Neuroprotective AgentsIBA 01/2004 - 02/2000
2	Levodopa (L Dopa)FDA LinkGeneric 06/2000 - 06/2000
1	Serum AlbuminIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	hydroxide ionIBA 01/2019
1	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2013
1	Advanced Glycation End ProductsIBA 04/2013
1	Alkaline PhosphataseIBA 03/2013
1	OsteocalcinIBA 03/2013
1	Collagen Type I (Type I Collagen)IBA 03/2013
1	Testosterone (Sustanon)FDA Link 03/2013
1	Follicle Stimulating Hormone (Follitropin)FDA Link 03/2013
1	Hormones (Hormone)IBA 03/2013
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 03/2013
1	GlucuronidesIBA 04/2012
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2012
1	Thromboplastin (Tissue Factor)IBA 01/2009
1	Doxazosin (Cardura)FDA LinkGeneric 10/2005
1	AutoantigensIBA 10/2005
1	RotenoneIBA 01/2005
1	InsecticidesIBA 01/2005
1	TubulinIBA 01/2005
1	PPAR gammaIBA 01/2004
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2004
1	CollagenIBA 10/2002
1	Cyclin EIBA 10/2001
1	Immunoglobulin M (IgM)IBA 08/2001
1	NitratesIBA 08/2001
1	NitritesIBA 08/2001
1	ranimustineIBA 07/2001
1	LenograstimIBA 07/2001
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2001
1	Streptozocin (Streptozotocin)FDA Link 03/2001
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 03/2001
1	Laminin (Merosin)IBA 02/2001
1	Indicators and Reagents (Reagents)IBA 02/2001
1	Immunologic Factors (Immunomodulators)IBA 02/2001
1	PicibanilIBA 02/2001
1	RoxithromycinIBA 02/2001
1	KalininIBA 02/2001
1	laminin alpha 3IBA 02/2001
1	Calcium-Binding ProteinsIBA 01/2001
1	Phenobarbital (Luminal)FDA Link 01/2001
1	Annexin A5IBA 01/2001
1	Glutathione (Reduced Glutathione)IBA 12/2000

Therapy/Procedure

5	Therapeutics 07/2001 - 01/2000
2	Drug Therapy (Chemotherapy) 08/2001 - 07/2001
1	Voice Training 01/2022
1	Resistance Training 01/2022
1	Hematopoietic Stem Cell Transplantation 12/2003
1	Cystectomy 11/2001
1	Radiotherapy 08/2001
1	Immunotherapy 02/2001
1	Transplantation 02/2001
1	X-Ray Film 02/2001